On the other hand, many studies have pointed toward out that EZH2/PRC2 activity or H3K27me3 may facilitate the disease progression to HCC via the repression of multiple tumor-suppressive microRNAs [45]. The gene discussed is EZH2; the disease is hepatocellular carcinoma.